# Additional Effect of Intrapulmonary Percussive Ventilation (IPV) on Respiration in People With Multiple Sclerosis (MS).

> **NCT04295616** · NA · TERMINATED · sponsor: **National Multiple Sclerosis Center** · enrollment: 5 (actual)

## Conditions studied

- Multiple Sclerosis

## Interventions

- **DEVICE:** Intrapulmonary percussive ventilation (IPV)
- **BEHAVIORAL:** Active breathing training

## Key facts

- **NCT ID:** NCT04295616
- **Lead sponsor:** National Multiple Sclerosis Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2020-01-13
- **Primary completion:** 2020-07-20
- **Final completion:** 2020-07-20
- **Target enrollment:** 5 (ACTUAL)
- **Why stopped:** Due to COVID-19 situation IPV is no longer allowed in the center
- **Last updated:** 2020-08-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04295616

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04295616, "Additional Effect of Intrapulmonary Percussive Ventilation (IPV) on Respiration in People With Multiple Sclerosis (MS).". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT04295616. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*